Clinical Trial Update: Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and early efficacy of BAFF-R CAR-T cells in adults with CD19-negative relapsed or refractory B-cell lymphoma; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• BAFF-R CAR-T Cells

Snippet

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | Conditions: B-cell Lymphoma | Phase 1 | Status: RECRUITING